Jason Chu | Author | SciTechnol | International Journal of Cardi

Jason Chu Author

Jangd01@nyumc.org

Subjects of specialization
Cardiovascular drug;, LD50; , Dihydropyridine

Affiliation
Department of Emergency Medicine New York University School of Medicine Bellevue Hospital Center New York, New York, USA

Biography

Jason Chu, Department of Emergency Medicine New York University School of Medicine Bellevue Hospital Center New York, New York, USA, The Novel Development of an Experimental Model of Dihydropyridine Calcium Channel Blocker Poisoning using Intravenous Amlodipine

Publications

Research Article Subscription

The Novel Development of an Experimental Model of Dihydropyridine Calcium Channel Blocker Poisoning using Intravenous Amlodipine

Author(s):

David Jang, Sean Donovan, Theodore Bania, Lewis Nelson, Robert Hoffman and Jason Chu

The Novel Development of an Experimental Model of Dihydropyridine Calcium Channel Blocker Poisoning using Intravenous Amlodipine

Cardiovascular drug poisoning remains a leading cause of fatality. Within this class, calcium channel blockers(CCBs) account for the majority of deaths. CCBs are typically categorized as dihydropyridines (i.e. amlodipine or nifedipine) versus the non-dihydropyridine (i.e. verapamil and diltiazem) which are the most potent and once considered the CCB type responsible for all CCB-related deaths. Most recently, dihydropyridine deaths have incr... view more»

DOI: 10.4172/2324-8602.1000121

Abstract HTML PDF